Clinical variables which serve as predictors of cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate.

PubWeight™: 0.93‹?›

🔗 View Article (PMID 8156499)

Published in Cancer on March 15, 1994

Authors

J B Thrasher1, H A Frazier, J E Robertson, R K Dodge, D F Paulson

Author Affiliations

1: Division of Urology, Duke University Medical Center, Durham, NC 27710.

Articles citing this

Epidemiology of urinary bladder cancer: from tumor development to patient's death. World J Urol (2007) 1.96

Bladder cancer in the elderly. Urol Oncol (2009) 1.26

The prognostic significance of preoperative leukocytosis and neutrophil-to-lymphocyte ratio in patients who underwent radical cystectomy for bladder cancer. Can Urol Assoc J (2015) 0.90

Classification and grading of the non-invasive urothelial neoplasms: recent advances and controversies. J Clin Pathol (2003) 0.83

High-grade hydronephrosis predicts poor outcomes after radical cystectomy in patients with bladder cancer. J Korean Med Sci (2010) 0.80

Gender-specific survival following radical cystectomy for pT4 bladder cancer. World J Urol (2013) 0.80

Risk stratification of survival by lymphovascular invasion, pathological stage, and surgical margin in patients with bladder cancer treated with radical cystectomy. Int J Clin Oncol (2011) 0.79

Prognostic Value of Pre-operative Renal Insufficiency in Urothelial Carcinoma: A Systematic Review and Meta-Analysis. Sci Rep (2016) 0.79

The prognostic role of pre-cystectomy hemoglobin levels in patients with invasive bladder cancer. World J Urol (2015) 0.76

Radical cystectomy over the age of 75 is safe and increases survival. BMC Geriatr (2012) 0.75

The effect of preoperative clinical variables on the 30- and 90-day morbidity and mortality after radical cystectomy: A single-centre study. Arab J Urol (2013) 0.75

Preoperative chronic kidney disease predicts poor oncological outcomes after radical cystectomy in patients with muscle-invasive bladder cancer. Oncotarget (2017) 0.75

Articles by these authors

Isolation of a human prostate carcinoma cell line (DU 145). Int J Cancer (1978) 4.04

Prognostic discrimination in "good-risk" chronic granulocytic leukemia. Blood (1984) 3.65

In vitro and in vivo efficacies of the azole SCH56592 against Cryptococcus neoformans. Antimicrob Agents Chemother (1996) 3.20

Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J Natl Cancer Inst (1993) 2.76

Results of radical prostatectomy in men with clinically localized prostate cancer. JAMA (1996) 2.74

A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811. Blood (1995) 2.43

Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. Cancer and Leukemia Group B. N Engl J Med (1995) 2.33

Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome. Radiother Oncol (1999) 2.25

Overexpression and mutation of p53 in epithelial ovarian cancer. Cancer Res (1991) 2.20

Hyperbaric oxygen improves tumor radiation response significantly more than carbogen/nicotinamide. Radiat Res (1997) 2.02

Prospective karyotype analysis in adult acute lymphoblastic leukemia: the cancer and leukemia Group B experience. Blood (1999) 1.85

Staging pelvic lymphadenectomy for carcinoma of the prostate risk versus benefit. J Urol (1980) 1.80

Cystic renal masses: usefulness of the Bosniak classification. Urol Radiol (1991) 1.80

Does of stage pT0 cystectomy specimen confer a survival advantage in patients with minimally invasive bladder cancer? J Urol (1994) 1.78

Serum androgens: associations with prostate cancer risk and hair patterning. J Androl (1997) 1.76

Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia. N Engl J Med (1989) 1.69

Total prostatoseminal vesiculectomy in the treatment of debilitating perineal pain. J Urol (1992) 1.60

Transient lower extremity neurapraxia associated with radical perineal prostatectomy: a complication of the exaggerated lithotomy position. J Urol (1998) 1.59

PTEN mutation in endometrial cancers is associated with favorable clinical and pathologic characteristics. Clin Cancer Res (1998) 1.58

Possible mechanism for seeding of tumor during radical prostatectomy. J Urol (1993) 1.52

Radical surgery versus radiotherapy for adenocarcinoma of the prostate. J Urol (1982) 1.50

Postoperative radiotherapy of the prostate for patients undergoing radical prostatectomy with positive margins, seminal vesicle involvement and/or penetration through the capsule. J Urol (1990) 1.48

Staging relationships and outcome in early stage testicular cancer: a report from the Testicular Cancer Intergroup Study. J Urol (1991) 1.47

Synaptonemal complex complement of man in spreads of spermatocytes, with details of the sex chromosome pair. Science (1975) 1.46

The prognostic significance of angiogenesis in epithelial ovarian carcinoma. Clin Cancer Res (1999) 1.43

Testicular cancer in blacks. A multicenter experience. Cancer (1994) 1.42

Risk of adverse events in children completing treatment for acute lymphoblastic leukemia: St. Jude Total Therapy studies VIII, IX, and X. J Clin Oncol (1991) 1.42

The shielding capacity of the standard military flak jacket against ballistic injury to the kidney. J Forensic Sci (1988) 1.39

Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine. Blood (2001) 1.38

Early onset baldness and prostate cancer risk. Cancer Epidemiol Biomarkers Prev (2000) 1.37

Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered. J Clin Oncol (1999) 1.36

Surgical management and prognosis of renal cell carcinoma invading the vena cava. J Urol (1991) 1.35

A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111. Blood (1998) 1.35

Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases. Invest Ophthalmol Vis Sci (1994) 1.34

Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. I. Correlation of receptor expression with prognostic factors in patients with ovarian cancer. Am J Obstet Gynecol (1991) 1.31

Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer. N Engl J Med (1987) 1.30

Radiation therapy and hyperthermia improve the oxygenation of human soft tissue sarcomas. Cancer Res (1996) 1.28

Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma. Gynecol Oncol (1999) 1.28

The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma. Gynecol Oncol (2000) 1.27

A new look at bladder neck obstruction by the food and drug administration regulators: guide lines for investigation of benign prostatic hypertrophy. Trans Am Assoc Genitourin Surg (1976) 1.26

Cytokine mRNA levels in rat ocular tissues after systemic endotoxin treatment. Invest Ophthalmol Vis Sci (1994) 1.26

Prognostic importance of mutations in the ras proto-oncogenes in de novo acute myeloid leukemia. Blood (1994) 1.22

The value of pathologic factors in predicting cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate. Cancer (1993) 1.21

Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: a Cancer and Leukemia Group B Study (8762). Blood (1992) 1.21

Parallel phase I studies of daunorubicin given with cytarabine and etoposide with or without the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age or older with acute myeloid leukemia: results of cancer and leukemia group B study 9420. J Clin Oncol (1999) 1.19

Acute retinal necrosis caused by reactivation of herpes simplex virus type 2. Am J Ophthalmol (1994) 1.17

Immunolocalization of integrins in the human retina. Invest Ophthalmol Vis Sci (1994) 1.15

Radical cystectomy for stages Ta, Tis and T1 transitional cell carcinoma of the bladder. J Urol (1994) 1.14

Heterotransplantation of a human prostatic adenocarcinoma cell line in nude mice. Cancer Res (1977) 1.14

Pilot study of dietary fat restriction and flaxseed supplementation in men with prostate cancer before surgery: exploring the effects on hormonal levels, prostate-specific antigen, and histopathologic features. Urology (2001) 1.13

Treatment options, selection, and satisfaction among African American and white men with prostate carcinoma in North Carolina. Cancer (1998) 1.12

Overexpression and mutation of p53 in endometrial carcinoma. Cancer Res (1992) 1.11

Results of radical prostatectomy in men with locally advanced prostate cancer: multi-institutional pooled analysis. Eur Urol (1997) 1.11

Delay in diagnosis and survival in testicular cancer: impact of effective therapy and changes during 18 years. J Urol (1990) 1.09

Analysis of survival in a retrospective study of 86 dogs with brain tumors. J Vet Intern Med (1991) 1.09

Sensitivity of hyperthermia trial outcomes to temperature and time: implications for thermal goals of treatment. Int J Radiat Oncol Biol Phys (1993) 1.08

Overexpression of HER-2/neu in endometrial cancer is associated with advanced stage disease. Am J Obstet Gynecol (1991) 1.07

Prognostic factors in renal cancer. Urol Clin North Am (1993) 1.04

Prognostic importance of structural chromosomal abnormalities in children with hyperdiploid (greater than 50 chromosomes) acute lymphoblastic leukemia. Blood (1989) 1.04

High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361). Blood (2001) 1.03

Proliferative index determination in prostatic carcinoma tissue: is there any additional prognostic value greater than that of Gleason score, ploidy and pathological stage? J Urol (1997) 1.02

Experience with Gleason's histopathologic grading in prostatic cancer. J Urol (1980) 1.00

Complications of radical cystectomy and urinary diversion: a retrospective review of 675 cases in 2 decades. J Urol (1992) 1.00

Gluteus medius tendon tears and avulsive injuries in elderly women: imaging findings in six patients. AJR Am J Roentgenol (1999) 1.00

The annual risk of melanoma progression. Implications for the concept of cure. Cancer (1992) 1.00

Hypodiploidy is associated with a poor prognosis in childhood acute lymphoblastic leukemia. Blood (1987) 1.00

Compensatory renal growth after unilateral ureteral obstruction. Kidney Int (1973) 0.99

Retinal pigment epithelial cells produce interleukin-1 beta and granulocyte-macrophage colony-stimulating factor in response to interleukin-1 alpha. Curr Eye Res (1993) 0.99

Immunolocalization of integrins in proliferative retinal membranes. Invest Ophthalmol Vis Sci (1994) 0.98

Advanced prostatic carcinoma: pulmonary manifestations. Radiology (1985) 0.98

Characterization of a human prostate adenocarcinoma cell line (DU 145) as a monolayer culture and as a solid tumor in athymic mice. Prog Clin Biol Res (1980) 0.97

Differential expression of mRNA coding for heparin-binding growth factor type 2 in human cells. J Cell Physiol (1988) 0.97

Prognostic significance of Ki-67 proliferation index in supratentorial fibrillary astrocytic neoplasms. Neurosurgery (1994) 0.97

Comparison of ultrasound-guided biopsies and prostatectomy specimens: predictive accuracy of Gleason score and tumor site. Urol Int (2001) 0.97

Spontaneous metastasis of cells of the human prostate carcinoma cell line PC-3 in athymic nude mice. J Urol (1982) 0.96

Evidence for a novel hybrid immunotoxin recognizing ricin A-chain by one antigen-combining site and a prostate-restricted antigen by the remaining antigen-combining site: potential for immunotherapy. Cancer Treat Rep (1985) 0.96

Value of immunophenotype in intensively treated adult acute lymphoblastic leukemia: cancer and leukemia Group B study 8364. Blood (1999) 0.95

The clinical significance of unconventional orchiectomy approaches in testicular cancer: a report from the Testicular Cancer Intergroup Study. J Urol (1988) 0.95

Racial disparity in the frequency of PTEN mutations, but not microsatellite instability, in advanced endometrial cancers. Clin Cancer Res (2000) 0.95

Hypersensitivity reactions to L-asparaginase do not impact on the remission duration of adults with acute lymphoblastic leukemia. Leukemia (1998) 0.94

Prognostic significance of the proliferation index in surgically resected non-small-cell lung cancer. Arch Surg (1993) 0.94

Squamous carcinoma of urinary bladder. Urology (1983) 0.94

Significance of lymphoglandular bodies in bone marrow aspiration smears. Diagn Cytopathol (2001) 0.94

Height at diagnosis of malignancies. Arch Dis Child (1987) 0.94

Cultured human retinal pigment epithelial cells express basic fibroblast growth factor and its receptor. Curr Eye Res (1989) 0.93

Potentiation of ifosfamide neurotoxicity, hematotoxicity, and tubular nephrotoxicity by prior cis-diamminedichloroplatinum(II) therapy. Cancer Res (1987) 0.93

Results and complications of pneumatic retinopexy. Ophthalmology (1988) 0.93

Viral neoplastic transformation of hamster prostate tissue in vitro. Science (1968) 0.93

Uveitis precipitated by nonpenetrating ocular trauma. Am J Ophthalmol (1991) 0.92

Diagnostic accuracy in fine-needle aspiration of soft tissue and bone lesions. Influence of clinical history and experience. Am J Clin Pathol (1999) 0.92